chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient felt dizzy, nauseated, ringing in ear, headache, blurred vision after getting vaccinated. Patient stated laying down made her feel worse. Pt sat up and vomit. Paramedics arrived. Vital signs stable. Pt still feel dizzy, stopped vomiting. Pt able to talk in sentences without resp distress. Pt stable. No transportation needed to hospital. Blood sugar 165 mg/dL. Allergic to penicillin.
pretty much left without much of a voice; Did not get the 2nd shingles shot; This case was reported by a consumer via  interactive digital media and described the occurrence of voice lowered in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and not applicable after receiving Shingles vaccine, the patient experienced voice lowered and incomplete course of vaccination. On an unknown date, the outcome of the voice lowered and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the voice lowered to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by patient himself/herself. The age group was not reported but was selected as an adult as per vaccine indication. The patient had experienced horrible reaction after the 1st dose, and he/she was pretty much left without much of a voice. Till the time of reporting, the patient did not receive the 2nd dose of Shingles vaccine, which led to incomplete course of vaccination. The follow-up would not possible as no contact details were available.
After the 2nd shot, I had a reaction that weekend on Friday of chills and fever and achy joints for a couple of days, but it passed. Over the course of months and probably around summertime, I was feeling tired and fatigued and coughing a lot and I didn't have a cold or a reason to cough and I had to cough to clear my lungs. When I went to see my Doctor for a checkup they discovered I had a heart murmur that was loud and I was sent to cardiologist to have an echocardiogram and results were that I have a leaky valve and regurgitation and I have an appointment to see my cardiologist next week and the Doctor told me that this is the cause of my shortness of breath and tiredness because the heart murmur will do that, so now I have to see cardiologist next week and he didn't feel like meds would help.
patient have felt is a sore arm muscle for a few days; Initial information received on 19-Nov-2020 regarding an unsolicited valid non-serious social media case received from a consumer.  This case involves a patient who have felt is a sore arm muscle for a few days (myalgia), while he/she received INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient have felt is a sore arm muscle for a few days (myalgia) (Unknown latency) following the administration of INFLUENZA VACCINE.  It was not reported if the patient received any corrective treatment.  The event outcome was reported as unknown.  There will be no information available on the batch number for this case.
two bumps under right under arm since a day after the vaccine. Two weeks later and bumps are still there.
On 3/22 I was stung by a wasp on my right foot. On 3/23 it itched, so I scratched it. It swelled up a little and turned pink.  Not long after, my shot site turned hard and reddish. It began to itch slightly. It took a few days for the itching and the swelling to go away. It was not too bad, so I didn't bother spending the $50 to go to the doctor.
Initially pain at injection site as well as mild generalized body aches starting approximately 10 hour after the vaccination.  Responded well to rest and tylenol PO.  Resolved slowly over the following 4-5 days.  Starting on 1/28/21 and lasting until 1/31/21, noted chest tightness and arrhythmia (unifocal PVC's) that would occur multiple times a day.   PVCs would last for 30-45 seconds and occur 2-4 times and hour.  Chest tightness occurred independent of the PVC's and would last 15-20 minutes, several times a day.  No treatment was done for these symptoms as the arrhythmia was not one that required treatment.  Starting on 2/6/21, noted bottoms of both feet started to feel very itchy with mild intermittent erythema noted on the bottoms of the innermost toes.  Within 24 hours, noted numbness and tingling sensation on the bottoms of both big toes, progressing slightly towards the ball of the foot.  Symptoms persisted almost continuously until 2/14/21 and then slowly waned until they resolved by 3/1/21.  Went to see a dermatologist on 2/15/21 to rule out a dermatologic cause.   She did not feel it was a dermatological issues and so had a COVID PCR test that day which was negative.
Initial report was received from a healthcare professional on 21 June 2013. A 65-year-old female patient received an intramuscular injection of ADACEL vaccine, lot number unknown (site and side of administration not reported), and a subcutaneous injection of Yellow Fever vaccine, lot number unknown (site and side of administration not reported) on 07 May 2013. Patient also received Hepatitis A vaccine (other manufacturer) within 4 weeks of other vaccinations (also reported as "on that date"). On 13 June 2013, 37 days post vaccination, the patient developed a rash on her neck and a fever which persisted to date. The physician did not think the events were related to the vaccine but he could not be sure. Shortly after the rash developed, the patient was admitted to the hospital and treated with antibiotics (records not immediately available, so unknown). The patient subsequently developed a diffuse rash biopsy of which suggested a drug related rash. The reporter has never seen such a localized rash (original rash) at a site away from administration site. He did not feel the event was related to the vaccine administration. The patient's outcome was not recovered.
About ten days out from the vaccine I had itching in my hands thighs on one side of my body. It was on the right side. It was unbearable itching and then I noticed hives. It lasted a three days after a Steroid injection , an antihistamine and a bacterial cream. I had been trying Benadryl which did not work. After three days I felt better and it did not return. I got the second dose and I did not have any reaction.
The provider ordered the Hepatitis A vaccine to be administered, but patient was given PREVNAR 13 inadvertently. The provider was informed in a timely manner. The patients parents were also notified of the error and no adverse reactions were noted.
Client reports waking up with a very sore injection site- which became hard and swollen like a "softball". Client also reports opposite arm was numb and tingley. Client reports it took four days to resolve (1/12). Today (1/13) some swelling is still palpable on site.  Denies redness or warmth and no redness is noted today. Denies headache or fevers.
faint; Dizziness; tachycardia; BP sys: 160; HR 120+,; This is a spontaneous report from a contactable consumer (patient himself). A 25-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249), via an unspecified route of administration on 22Jan2021 10:00 at single dose in left arm for COVID-19 immunization. The patient previously took diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (TDAP) on an unspecified date for immunization and had had reaction to this vaccine with swelling of arm and surrounding lymph nodes. The patient had no other medical history was reported. The patient's concomitant medications were none. The patient had no other vaccine in four weeks and no other medications in two weeks. The patient experienced dizziness, tachycardia, BP sys (systolic blood pressure): 160, HR 120+, and faint on 22Jan2021 10:30 and events result in Emergency room/department or urgent care. The outcome of the events was recovering.
Headaches almost daily; This case was reported by a consumer via interactive digital media and described the occurrence of headache in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 14th October 2022, the patient received the 1st dose of Shingrix. In October 2022, less than 3 weeks after receiving Shingrix, the patient experienced headache. On an unknown date, the outcome of the headache was not recovered/not resolved.   It was unknown if the reporter considered the headache to be related to Shingrix.     Additional Information: GSK Receipt Date: 31-Oct-2022 Reporter's comment: This case was reported by the patient via interactive digital media. The patient had his/her first Shingrix shot and since then he/she had been experiencing headaches almost daily.  The patient asked was this common or should he/she report this to his/her doctor. Additional supportive information: The follow-up would not possible, as no contact details were available.
Hospitalization for COVID-19 with cough, questionable chest pain, metabolic encephalopathy on dates 8/22/2023- 8/31/2023. Treated with vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Ya I'm sure everytime I've gotta a flu shot I've had the flu care to explain that??; Initial information received on 10-Oct-2020 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case is linked to case 2020SA294157.  This case involves an unknown age patient who reported that patient everytime gotta a flu shot  patient have had the flu care to explain that (Influenza), while he/she received vaccine INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE [FLUZONE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date the patient started taking INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE (dosage unknown) (with an unknown batch number)   On an unknown date, the patient reported that everytime gotta a flu shot  patient have had the flu care to explain that (influenza) Unknown latency following the administration of INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE.  Final diagnosis was Influenza.   Action taken was not applicable.  It was not reported if the patient received a corrective treatment.  The event outcome was unknown.  There will be no information available on the batch number for this case.
Information has been received from a consumer concerning her daughter who on an unknown date was vaccinated with a dose of ROTATEQ. Secondary suspect therapy included ROTATEQ which the patient concomitantly received with PREVNAR. It was reported that the patient had an adverse reaction to the above vaccines. The patient sought unspecified medical attention. The patient's final outcome was not reported. Follow-up information has been received from a consumer concerning her 8 weeks old daughter who in October 2007, was vaccinated with a dose of ROTATEQ (manufacturer unknown). Secondary suspect therapy included PREVNAR and PEDVAXHIB (manufacturer unknown). In October 2007 20 minutes after receiving the shots, the patient cried for 10 hours straight a day for months. The patient's mother called the physician's office and they treated her daughter for some kind of allergy, so the patient's mother had to watch what she ate as for she was nursing. In December 2007, the patient had just started to stop the crying and received "more shots". The patient immediately started crying and never stopped. She would not nurse. The patient's mother called the physician's office who recommended putting the patient on soy formula and MYLICON gas drops. The patient stopped the crying sessions at the end of January 2008. In February 2008, the patient got a "series of shots" and started up again. The patient's mother also stated that it was awful to see her child suffer, cry and then after 10 hours of crying, just see her laying there listless. The patient's mother was afraid her child would never wake-up the next morning, so she would lay on a floor next to her daughter's cribs, checking her to make sure she was breathing every 20 minutes. After that the patient's mother along with the office manager who gives shots and the doctor had a discussion. The physician recommended separating all the vaccines. So from February 2008 the patient has gotten all individual vaccines instead of combos. The patient has individually received the mumps vaccine (manufacturer unknown) and rubella vaccine (manufacturer unknown). The patient's mother stated her daughter has not received MMR and that she refuses to give her child the "chickenpox vaccine". It was also mentioned that the patient's mother wants her child vaccinated but in a controlled setting since she believes that her daughter had a reaction, because "colic babies do not stop being colic when you separate shots". Although her daughter's pediatrician "swears it was not due to a reaction" the patient's mother received information about two components in vaccines that would cause inconsolable crying. The patient's mother wants her child vaccinated with separate vaccines, so she and the doctors know which ones in particular her daughter has a reaction to. It was reported that the patient's pediatrician is going to wait until she goes to school to received MMR, unless she finds individual vaccines available. No further information is available.
12/14/2019; Patient received two shots, Fluzone High Dose and PneumoVax 23, on his right upper arm.  Fluzone HD was on the upper part, and PneumoVax 23 was on the lower part.   12/19/2019; Patient showed up at the pharmacy and stated that he had developed a severe reaction to the shots.  He described, "The upper arm was severely inflamed along with a fever for the next 24 hours."  (Patient received the Fluzone HD in 2018 and did not have any complaints of)
First shot in April do I need to start the process again; Just getting over having COVID; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (First shot in April do I need to start the process again) and COVID-19 (Just getting over having COVID) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (First shot in April do I need to start the process again) and COVID-19 (Just getting over having COVID). At the time of the report, PRODUCT DOSE OMISSION ISSUE (First shot in April do I need to start the process again) outcome was unknown and COVID-19 (Just getting over having COVID) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products were not provided. Treatment medication were not reported.   Reporter did not allow further contact
Rash at injection site, followed by pruritic rash around waist, feet and toes.
Patient was given a Moderna Vaccine (first dose) during a time when this vaccine has not been approved for population under 18 years of age. No adverse reactions have been reported
Chills, fever as high a 102 duration 3 days, muscle aches, fatigue, loss of appetite.
1) 18 hours after vaccines given, Temperature 104 for 36 hours.  2)  24 hours after vaccines given, onset of vomiting for 24 hours. 3) 44 hours after vaccines, asymptomatic.
Possible Bell's Palsy Rx of Prednisone 60mg Daily x7 days Valacyclovir 1000mg TID x7 days
Developed a generalized rash there weeks after second dose of COVID vaccine all over my body that was itchy. Prescribed a short course of prednisone with hydroxyzine which helped improve it for a few days, However, it recurred soon after the prednisone course and was prescribed a higher dose of prednisone for 5 days along with ranitidine and zyrtec. The rash improved but by March 24 it had recurred again. I saw my PMD who suggested a dermatologist, who diagnosed it as an eczema flare up then prescribed an even higher dose of prednisone for two weeks. This cleared the rash but it persisted on my face and scalp. Followed up for two more visits with Dermatologist until found steroid creams that cleared the scalp rash but facial redness has persisted. Currently trying Eucrisa.
Hospitalization for COVID with required intubation. Family out of the country with COVID, patient was with family and had family ill with COVID and some expired there. Patient wanted to return there but required intubation in ICU.
This spontaneous report as received from a registered nurse refers to a multiple unspecified group of patients of unknown age and gender. On an unknown date the patients were vaccinated with ROTATEQ (dose, frequency, lot #: not specified, orally) that was improperly stored. Concomitant medication was not reported. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Diagnosis of Narrow Angle Glaucoma-Left 09/19/2022. I have been dealing with the migraines in the left eye which remained the same. During my annual exam, I was given a new diagnosis. The initial diagnosis was Episodic Migraines. It does not appear to cause any worsening in the original condition. I was advised to go the nearest emergency if I noticed change in my vision. I went back to the doctor on October 07 and had a Peripheral Vision Test completed which showed there was weakness in the left eye.
Loss LOC. Has history of these s/s from injections. Weakness, diaphoretic this injection as well. Seen by EMS and discharged home with family member.  HR= 59 B.P.=130/70 RR =16
Throat feels tight; Can hardly breathe; This spontaneous case was received on 09-Nov-2021 from other non-healthcare professional (the patient) via The Regulatory Authority (reference number: SEQW21-05224) and concerned a 71-year-old, female patient.  The patient's concurrent conditions included MS (multiple sclerosis), colitis, and allergy to sea food. The patient's concomitant medications included Anoro Ellipta (umeclidinium bromide, vilanterol trifenatate), Albuterol sulfate (salbutamol sulfate), Alendronate (alendronate sodium), amlodipine, budesonide, clonazepam, propranolol and Venlafaxine (venlafaxine hydrochloride) all used for unreported indication. The patient received Fluad Quad last year with no side effect.  On an unknown day in Sep-2021, the patient was vaccinated with Fluad Quadrivalent (Influenza vaccine, inactivated influenza virus surface antigen (subunit), egg-derived, mf59; dose 0.5 ml, route of administration: intramuscular and anatomical location: deltoid) for influenza prophylaxis. The batch number was not reported.  On unknown day in Sep-2021, an unknown amount of time after receiving Fluad Quadrivalent, the patient experienced a severe reaction, she could hardly breathe and her throat felt tight. The patient was treated with Anoro Ellipta (umeclidinium bromide, vilanterol trifenatate).  The outcome of the events was unknown.   The reporter assessed the events to be related to Fluad Quadrivalent.  The events were considered to be medically significant by a Physician within Seqirus' Pharmacovigilance and Risk Management Department.  Company comment: A 71-year-old, female patient developed throat tightness causing dyspnoea an unknown amount of time after vaccination with the suspect product Fluad Quadrivalent. Causality for the reported events is unassessable due to unclear chronology.; Sender's Comments: A 71-year-old, female patient developed throat tightness causing dyspnoea an unknown amount of time after vaccination with the suspect product Fluad Quadrivalent. Causality for the reported events is unassessable due to unclear chronology.
This spontaneous report as received from a physician via representative refers to a 42 year old female patient with diabetes, unspecified type. On 28-OCT-2014 (Tuesday) the patient was vaccinated with the first dose of PNEUMOVAX 23 (route, dose and lot # not reported) in unspecified anatomical sites. Concomitant therapies included Tdap vaccine given on 28-OCT-2014 in unspecified anatomical sites. On 29-OCT-2014 (Wednesday), the patient experienced difficulty breathing. The patient sought medical attention at an unspecified urgent care clinic, where she received treatment in the form of epinephrine injection. The patient was also experiencing "throat swelling" and an unspecified fever in October 2014, specified date unknown. On the following day on 30-OCT-2014, the patient reported to the physician's staff by phone call that her difficulty breathing seemed to resolve after she received the epinephrine injection, specified time unknown, in October 2014. The patient also informed the physician's staff that, on 30-OCT-2014, the patient experienced "one unspecified arm was very swollen and sore". The patient had not been examined by the physician since this event. At the time of reporting, the patient was recovering from "throat swelling", "unspecified fever" and "one unspecified arm was very swollen and sore". The events "difficulty breathing" and "throat swelling" were considered to be medically significant by reporter as the reporter said that "difficulty breathing" and "throat swelling" were considered serious health risks and the epinephrine injection was considered an intervention to prevent serious criteria. Action taken with PNEUMOVAX 23 due to the events were not applicable. The causality between the vaccination PNEUMOVAX 23 and all events were not provided. Additional information has been requested.
Initial report received from a healthcare professional on 25 September 2013. A39-year old female patient had received an intramuscular dose of ADACEL vaccine (batch number: C4426AA and anatomical site of administration was not reported) on 25 September 2013. The patient was pregnant at the time of vaccination. The patient's last menstrual period date was 11 February 2013. The estimated date of delivery was 18 November 2013. At the time of the report, the patient had not experienced any adverse events. Patients health during pregnancy, risk factors, concomitant medication and treatment for infertility were not reported. Documents held by sender: none.